Tag: Hatch-Waxman Act impact on pharmaceutical industry
Understanding the Impact of Hatch-Waxman and New-Patient Visit Times in Healthcare
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues...